🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Carac 0.5% cream is approved for daily topical treatment of AK's for up to ...
Status
Completed
Location
Wake Forest University Health Sciences Department of Dermatology
Start Date
2011-01-05
Trial ID
NCT03037541
Treatments Being Tested
The purpose of this study is to assess the safety of the skin balancing gel...
Status
Unknown
Location
Integrative Skin and Research
Start Date
2023-09-01
Trial ID
NCT05941065
Treatments Being Tested
This study evaluates a nature-based sensitive skin regimen (NBSSR), as a su...
Status
Completed
Location
Dermatology Consulting Services
Start Date
2018-01-01
Trial ID
NCT03392558
Treatments Being Tested
The aim of the study is to determine the efficacy of MAL + Aktilite versus ...
Status
Completed
Location
IPS Universitaria - Universidad de Antioquia
Start Date
2008-02
Trial ID
NCT00629317
Treatments Being Tested
This study is to evaluate the efficacy and safety of Tri-Luma® Cream (fluoc...
Status
Terminated
Location
Dermatology/Cosmetic Laser Associates of La Jolla, Inc.
Start Date
2008-01
Trial ID
NCT00669071
Subjects having mild-to-moderate crepiness, photodamage, and loss of firmne...
Status
Completed
Location
Ablon Skin Institute & Research Center
Start Date
2025-08-12
Trial ID
NCT07398989
Treatments Being Tested
To evaluate the efficacy of a tripeptide/hexapeptide topical (Alastin Regen...
Status
Completed
Location
University of Rochester Medical Center
Start Date
2020-02-13
Trial ID
NCT04606134
This single-center, open-label, clinical case trial was conducted to evalua...
Status
Completed
Location
Tone Dermatology
Start Date
2023-04-24
Trial ID
NCT06633731
Treatments Being Tested
Topical metronidazole is a widely used first line treatment for erythemotel...
Status
Completed
Location
Duke University Medical Center
Start Date
2024-09-03
Trial ID
NCT06434519
Subjects having mild-to-severe plaque psoriasis, with active target lesion ...
Status
Completed
Location
Southeast Dermatology Specialists, LLC
Start Date
2024-04-08
Trial ID
NCT06357221
Treatments Being Tested